0001752724-20-242977.txt : 20201124 0001752724-20-242977.hdr.sgml : 20201124 20201124094840 ACCESSION NUMBER: 0001752724-20-242977 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201124 PERIOD START: 20201231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Morgan Stanley China A Share Fund, Inc. CENTRAL INDEX KEY: 0001368493 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-21926 FILM NUMBER: 201340691 BUSINESS ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 800-231-2608 MAIL ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 NPORT-P 1 primary_doc.xml NPORT-P false 0001368493 XXXXXXXX Morgan Stanley China A Share Fund, Inc. 811-21926 0001368493 54930045HQ1UNO6FR635 522 FIFTH AVENUE NEW YORK 10036 800-231-2608 Morgan Stanley China A Share Fund, Inc. 54930045HQ1UNO6FR635 2020-12-31 2020-09-30 N 564489545.02 1012776.68 563476768.34 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 24480189.23000000 N REFUNDABLE DEPOSIT SHANGHAI NON SECURITY ASSET EQUITY N/A REFUNDABLE DEPOSIT SHANGHAI NON SECURITY ASSET EQUITY 000000000 2006821.98000000 NS 294661.55000000 0.052293469146 Long STIV CORP CN N 3 N N N Foxconn Industrial Internet Co Ltd N/A Foxconn Industrial Internet Co Ltd 000000000 18332396.00000000 NS 36780211.32000000 6.527369607154 Long EC CORP CN N 2 N N N Jiangsu Nhwa Pharmaceutical Co Ltd N/A Jiangsu Nhwa Pharmaceutical Co Ltd 000000000 1958091.00000000 NS 4425170.95000000 0.785333344449 Long EC CORP CN N 2 N N N China Pacific Insurance Group Co Ltd 529900BA5ILEL308WX03 China Pacific Insurance Group Co Ltd 000000000 5821200.00000000 NS 16625388.66000000 2.950501173096 Long EC CORP CN N 2 N N N FOCUSED PHOTONICS HANGZHOU A N/A FOCUSED PHOTONICS HANGZHOU A 000000000 1638100.00000000 NS 3410950.84000000 0.605340101251 Long EC CORP CN N 2 N N N China Yangtze Power Co Ltd 3003008VX8JFJXA6QP74 China Yangtze Power Co Ltd 000000000 9641907.00000000 NS 27159920.96000000 4.820060468511 Long EC CORP CN N 2 N N N China Resources Sanjiu Medical & Pharmaceutical Co Ltd N/A China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000000000 13533438.00000000 NS 50969698.34000000 9.045572276237 Long EC CORP CN N 2 N N N Inner Mongolia Yili Industrial Group Co Ltd 3003002Q2A863JPQFH06 Inner Mongolia Yili Industrial Group Co Ltd 000000000 2250615.00000000 NS 12777187.41000000 2.267562413911 Long EC CORP CN N 2 N N N Bank of Communications Co Ltd 549300AX1UM10U30HK09 Bank of Communications Co Ltd 000000000 21263539.00000000 NS 14199149.19000000 2.519917410584 Long EC CORP CN N 2 N N N Unisplendour Corp Ltd 300300Z3RHZRXCNTRC53 Unisplendour Corp Ltd 000000000 3301577.00000000 NS 12385995.60000000 2.198137757567 Long EC CORP CN N 2 N N N China National Accord Medicines Corp Ltd N/A China National Accord Medicines Corp Ltd 000000000 527614.00000000 NS 3589758.11000000 0.637072956987 Long EC CORP CN N 2 N N N Midea Group Co Ltd 3003003TRPHLHZD2IF61 Midea Group Co Ltd 000000000 556192.00000000 NS 5961166.81000000 1.057925924357 Long EC CORP CN N 2 N N N Shandong Publishing & Media Co Ltd N/A Shandong Publishing & Media Co Ltd 000000000 19622334.00000000 NS 17812792.70000000 3.161229300096 Long EC CORP CN N 2 N N N Baidu Inc 254900AL64IANZYI1E02 Baidu Inc 056752108 18188.00000000 NS USD 2302418.92000000 0.408609378303 Long EC CORP KY N 1 N N N Jiangsu Expressway Co Ltd 529900UWWTWZ6AKLYD43 Jiangsu Expressway Co Ltd 000000000 8472291.00000000 NS 11843310.17000000 2.101827588187 Long EC CORP CN N 2 N N N Mayinglong Pharmaceutical Group Co Ltd N/A Mayinglong Pharmaceutical Group Co Ltd 000000000 2454040.00000000 NS 7561272.84000000 1.341896110868 Long EC CORP CN N 2 N N N Shenzhen Airport Co Ltd 3003009W045RIKRBZI44 Shenzhen Airport Co Ltd 000000000 7096035.00000000 NS 8958375.87000000 1.589839434976 Long EC CORP CN N 2 N N N Beijing Thunisoft Corp Ltd 300300ARLN2H6DSZJ004 Beijing Thunisoft Corp Ltd 000000000 5420320.00000000 NS 19107336.32000000 3.390971446132 Long EC CORP CN N 2 N N N Jiangsu Hengrui Medicine Co Ltd N/A Jiangsu Hengrui Medicine Co Ltd 000000000 584023.00000000 NS 7731742.14000000 1.372149230353 Long EC CORP CN N 2 N N N China Vanke Co Ltd 529900E66UJ2DWY7KW55 China Vanke Co Ltd 000000000 5969072.00000000 NS 24695526.61000000 4.382705374482 Long EC CORP CN N 2 N N N Morgan Stanley & Co. LLC 549300BI6Y5SI6BYPB26 Morgan Stanley Institutional Liquidity Funds - Government Portfolio 61747C707 357445.86000000 NS USD 357445.86000000 0.063435775897 Long STIV RF US N 1 N N N Shanghai Pharmaceuticals Holding Co Ltd 30030029J1KKCBY19820 Shanghai Pharmaceuticals Holding Co Ltd 000000000 17953400.00000000 NS 30112471.35000000 5.344048422566 Long EC CORP CN N 2 N N N FOCUSED PHOTONICS HANGZHOU A N/A FOCUSED PHOTONICS HANGZHOU A REIT 000000000 246100.00000000 NS 512444.30000000 0.090943287956 Long EC CN N 2 N N N Huaneng Lancang River Hydropower Inc 30030082YV5CD400SM55 Huaneng Lancang River Hydropower Inc 000000000 42931972.00000000 NS 26358103.94000000 4.677762317983 Long EC CORP CN N 2 N N N Huatai Securities Co Ltd 3003009ABT0UCWO79Q77 Huatai Securities Co Ltd 000000000 7384515.00000000 NS 22397096.51000000 3.974803890492 Long EC CORP CN N 2 N N N Guangzhou Haige Communications Group Inc Co 300300DDUUICKXUNQI85 Guangzhou Haige Communications Group Inc Co 000000000 3397902.00000000 NS 5864229.75000000 1.040722542523 Long EC CORP CN N 2 N N N Shenzhen Gas Corp Ltd 300300FUFI5P7GG85C19 Shenzhen Gas Corp Ltd 000000000 13533007.00000000 NS 13665245.22000000 2.425165683450 Long EC CORP CN N 2 N N N YUNNAN BAIYAO GROUP CO LTD A N/A YUNNAN BAIYAO GROUP CO LTD A 000000000 1110200.00000000 NS 15675149.77000000 2.781862651796 Long EC CORP CN N 2 N N N Weichai Power Co Ltd 529900OKTPKBG85F9502 Weichai Power Co Ltd 000000000 3051072.00000000 NS 6790382.36000000 1.205086481205 Long EC CORP CN N 2 N N N Joincare Pharmaceutical Group Industry Co Ltd 3003006PUWUKPH72TS46 Joincare Pharmaceutical Group Industry Co Ltd 000000000 2520682.00000000 NS 6331786.19000000 1.123699599657 Long EC CORP CN N 2 N N N FOCUSED PHOTONICS HANGZHOU A N/A FOCUSED PHOTONICS HANGZHOU A 000000000 652849.00000000 NS 1352092.97000000 0.239955406499 Long EC CORP CN N 2 N N N Guangzhou Restaurant Group Co Ltd N/A Guangzhou Restaurant Group Co Ltd 000000000 3811291.00000000 NS 19910540.99000000 3.533515862358 Long EC CORP CN N 2 N N N Haier Smart Home Co Ltd 3003002BYTNGNJTWSH07 Haier Smart Home Co Ltd 000000000 5440432.00000000 NS 17522507.85000000 3.109712562173 Long EC CORP CN N 2 N N N Industrial & Commercial Bank of China Ltd 5493002ERZU2K9PZDL40 Industrial & Commercial Bank of China Ltd 000000000 38464383.00000000 NS 27835978.07000000 4.940040057375 Long EC CORP CN N 2 N N N Zhaojin Mining Industry Co Ltd 3003007KU2DRDX06PN04 Zhaojin Mining Industry Co Ltd 000000000 6381500.00000000 NS 7848481.28000000 1.392866879520 Long EC CORP CN N 2 N N N REFUNDABLE DEPOSIT SHENZHEN NON SECURITY ASSET EQUITY N/A REFUNDABLE DEPOSIT SHENZHEN NON SECURITY ASSET EQUITY 000000000 1505116.49000000 NS 220996.17000000 0.039220103190 Long STIV CORP CN N 3 N N N China Merchants Shekou Industrial Zone Holdings Co Ltd 300300T3ACALX7NIPW13 China Merchants Shekou Industrial Zone Holdings Co Ltd 000000000 8179477.00000000 NS 18294356.42000000 3.246692223690 Long EC CORP CN N 2 N N N Southern Publishing & Media Co Ltd 30030038NR4CDSDY3592 Southern Publishing & Media Co Ltd 000000000 2132261.00000000 NS 2768647.89000000 0.491350849859 Long EC CORP CN N 2 N N N Guangxi Guiguan Electric Power Co Ltd 300300SZQP4SCND2NH61 Guangxi Guiguan Electric Power Co Ltd 000000000 27357380.00000000 NS 19281040.05000000 3.421798578635 Long EC CORP CN N 2 N N N Yunnan Baiyao Group Co Ltd N/A Yunnan Baiyao Group Co Ltd 000000000 550530.00000000 NS 8269202.21000000 1.467532057153 Long EC CORP CN N 2 N N N 2020-10-22 Morgan Stanley China A Share Fund, Inc. Francis Smith Francis Smith Principal Financial Officer XXXX NPORT-EX 2 NPORT_5835816210636985.htm

 

Morgan Stanley China A Share Fund, Inc.

Portfolio of Investments

Third Quarter Report

September 30, 2020 (unaudited)

 

   Shares   Value
(000)
 
Common Stocks  (95.6%)        
Banks  (7.5%)          
Bank of Communications Co., Ltd., Class A   21,263,539   $14,199 
Industrial & Commercial Bank of China Ltd., Class A   38,464,383    27,836 
         42,035 
Capital Markets  (4.0%)          
Huatai Securities Co. Ltd., Class A   7,384,515    22,397 
           
Commercial Services & Supplies  (0.9%)          
Focused Photonics Hangzhou, Inc., Class A (a)   2,537,049    5,276 
           
Communications Equipment  (1.0%)          
Guangzhou Haige Communications Group, Inc. Co., Class A   3,397,902    5,864 
           
Electronic Equipment, Instruments & Components  (8.7%)          
Foxconn Industrial Internet Co. Ltd., Class A   18,332,396    36,780 
Unisplendour Corp. Ltd., Class A   3,301,577    12,386 
         49,166 
Food Products  (2.3%)          
Inner Mongolia Yili Industrial Group Co., Ltd., Class A   2,250,615    12,777 
           
Gas Utilities  (2.4%)          
Shenzhen Gas Corp. Ltd., Class A   13,533,007    13,665 
           
Health Care Providers & Services  (6.0%)          
China National Accord Medicines Corp. Ltd., Class A   527,614    3,590 
Shanghai Pharmaceuticals Holding Co., Ltd. H Shares (b)   17,953,400    30,112 
         33,702 
Hotels, Restaurants & Leisure  (3.5%)          
Guangzhou Restaurant Group Co. Ltd., Class A   3,811,291    19,911 
           
Household Durables  (4.2%)          
Haier Smart Home Co., Ltd., Class A   5,440,432    17,523 
Midea Group Co., Ltd., Class A   556,192    5,961 
         23,484 
Independent Power & Renewable Electricity Producers  (12.9%)          
China Yangtze Power Co., Ltd., Class A   9,641,907    27,160 
Guangxi Guiguan Electric Power Co., Ltd., Class A   27,357,380    19,281 
Huaneng Lancang River Hydropower, Inc., Class A   42,931,972    26,358 
         72,799 
Insurance  (2.9%)          
China Pacific Insurance Group Co., Ltd. H Shares (b)   5,821,200    16,625 
           
Interactive Media & Services  (0.4%)          
Baidu, Inc. ADR (a)   18,188    2,303 
           
Machinery  (1.2%)          
Weichai Power Co. Ltd., Class A   3,051,072    6,790 
           
Media  (3.7%)          
Shandong Publishing & Media Co. Ltd., Class A   19,622,334    17,813 
Southern Publishing & Media Co., Ltd., Class A   2,132,261    2,769 
         20,582 
           

 

 

 

 

Morgan Stanley China A Share Fund, Inc.

Portfolio of Investments

Third Quarter Report

September 30, 2020 (unaudited)(cont’d)

 

Metals & Mining  (1.4%)            
Zhaojin Mining Industry Co., Ltd. H Shares (b)     6,381,500       7,849  
                 
Pharmaceuticals  (17.9%)                
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Class A     13,533,438       50,970  
Jiangsu Hengrui Medicine Co., Ltd., Class A     584,023       7,732  
Jiangsu Nhwa Pharmaceutical Co. Ltd., Class A     1,958,091       4,425  
Joincare Pharmaceutical Group Industry Co. Ltd., Class A     2,520,682       6,332  
Mayinglong Pharmaceutical Group Co. Ltd., Class A     2,454,040       7,561  
Yunnan Baiyao Group Co., Ltd., Class A     1,660,730       23,944  
              100,964  
Real Estate Management & Development  (7.6%)                
China Merchants Shekou Industrial Zone Holdings Co., Ltd., Class A     8,179,477       18,294  
China Vanke Co., Ltd., Class A     5,969,072       24,696  
              42,990  
Software  (3.4%)                
Beijing Thunisoft Corp., Ltd., Class A     5,420,320       19,107  
                 
Transportation Infrastructure  (3.7%)                
Jiangsu Expressway Co., Ltd., Class A     8,472,291       11,843  
Shenzhen Airport Co., Ltd., Class A     7,096,035       8,959  
              20,802  
Total Common Stocks (Cost $532,676)             539,088  
Short-Term Investment  (0.1%)                
Investment Company  (0.1%)                
Morgan Stanley Institutional Liquidity Funds - Government Portfolio - Institutional Class (c) (Cost $357)     357,446       357  
Total Investments (95.7%) (Cost $533,033)  (d)(e)(f)             539,445  
Other Assets in Excess of Liabilities (4.3%)             24,030  
Net Assets (100.0%)           $ 563,475  

 

 

   
(a) Non-income producing security.
(b) Security trades on the Hong Kong exchange.
(c) The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio - (the "Liquidity Funds"), an open-end management investment company managed by the Adviser. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the nine months ended September 30, 2020, advisory fees paid were reduced by approximately $2,000 relating to the Fund's investment in the Liquidity Funds.
(d) The approximate fair value and percentage of net assets, $515,834,000 and 91.6%, respectively, represent the securities that have been fair valued under the fair valuation policy for international investments as described in the Notes to the Portfolio of Investments.
(e) The Fund is permitted to purchase and sell securities ("cross-trade") from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Directors in compliance with Rule 17a-7 under the Act (the "Rule"). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the nine months ended September 30, 2020, the Fund did not engage in any cross-trade transactions.
(f) At September 30, 2020, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is approximately $31,704,000 and the aggregate gross unrealized depreciation is approximately $25,292,000, resulting in net unrealized appreciation of approximately $6,412,000.
 
ADR American Depositary Receipt.
   

 

 

 

 

Morgan Stanley China A Share Fund, Inc.

Portfolio of Investments

Third Quarter Report

September 30, 2020 (unaudited)(Cont’d)

 

Portfolio Composition
Classification     Percentage of
Total Investments
 
Other*     36.7 %
Pharmaceuticals     18.7  
Independent Power & Renewable Electricity Producers     13.5  
Electronic Equipment, Instruments & Components     9.1  
Real Estate Management & Development     8.0  
Banks     7.8  
Health Care Providers & Services     6.2  
Total Investments     100.0 %

 

 

* Industries and/or investment types representing less than 5% of total investments.

 

 

 

 

Morgan Stanley China A Share Fund, Inc.

 

Notes to the Portfolio of Investments September 30, 2020 (unaudited) 

 

Security Valuation: (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges. If only bid prices are available then the latest bid price may be used. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (2) all other equity portfolio securities for which over-the-counter (“OTC”) market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers; (3) certain portfolio securities may be valued by an outside pricing service/vendor approved by the Fund's Board of Directors (the "Directors"). The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads and/or other market data and specific security characteristics. Alternatively, if a valuation is not available from an outside pricing service/vendor, and the security trades on an exchange, the security may be valued at its latest reported sale price (or at the exchange official closing price if such exchange reports an official closing price), prior to the time when assets are valued. If there are no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available in the relevant exchanges. If only bid prices are available then the latest bid price may be used. If Morgan Stanley Investment Management Inc. (the “Adviser”), a wholly-owned subsidiary of Morgan Stanley, determines that the price provided by the outside pricing service/vendor or exchange does not reflect the security’s fair value or is unable to provide a price, prices from brokers or dealers may also be utilized. In these circumstances, the value of the security will be the mean of bid and asked prices obtained from brokers or dealers; (4) when market quotations are not readily available, including circumstances under which the Adviser determines that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security’s market value, portfolio securities are valued at their fair value as determined in good faith under procedures established by and under the general supervision of the Directors. Occasionally, developments affecting the closing prices of securities and other assets may occur between the times at which valuations of such securities are determined (that is, close of the foreign market on which the securities trade) and the close of business of the New York Stock Exchange (“NYSE”). If developments occur during such periods that are expected to materially affect the value of such securities, such valuations may be adjusted to reflect the estimated fair value of such securities as of the close of the NYSE, as determined in good faith by the Directors or by the Adviser using a pricing service and/or procedures approved by the Directors; (5) quotations of foreign portfolio securities, other assets and liabilities and forward contracts stated in foreign currency are translated into U.S. dollar equivalents at the prevailing market rates prior to the close of the NYSE; and (6) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value as of the close of each business day.

 

 

 

 

The Directors have responsibility for determining in good faith the fair value of the investments, and the Directors may appoint others, such as the Fund's Adviser or a valuation committee, to assist the Directors in determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Directors. Under procedures approved by the Directors, the Fund's Adviser has formed a Valuation Committee whose members are approved by the Directors. The Valuation Committee provides administration and oversight of the Fund’s valuation policies and procedures, which are reviewed at least annually by the Directors. These procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value. 

 

Fair Value Measurement: FASB Accounting Standards CodificationTM ("ASC") 820, "Fair Value Measurement" (“ASC 820”), defines fair value as the value that the Fund would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent buyer in the principal market, or in the absence of a principal market, the most advantageous market for the investment or liability. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs) and (2) inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in determining the value of the Fund's investments. The inputs are summarized in the three broad levels listed below: 

 

Level 1 – unadjusted quoted prices in active markets for identical investments       

 

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.) 

 

Level 3 – significant unobservable inputs including the Fund’s own assumptions in determining the fair value of investments. Factors considered in making this determination may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for exchange-traded securities), analysis of the issuer's financial statements or other available documents and, if necessary, available information concerning other securities in similar circumstances. 

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security. 

 

 

 

 

The following is a summary of the inputs used to value the Fund's investments as of September 30, 2020: 

 

Investment Type  Level 1
Unadjusted
quoted
prices
(000)
   Level 2
Other
significant
observable
inputs
(000)
   Level 3
Significant
unobservable
inputs
(000)
   Total
(000)
 
Assets:
Common Stocks                    
Banks  $   $42,035   $   $42,035 
Capital Markets       22,397        22,397 
Commercial Services & Supplies       5,276        5,276 
Communications Equipment       5,864        5,864 
Electronic Equipment, Instruments & Components       49,166        49,166 
Food Products       12,777        12,777 
Gas Utilities       13,665        13,665 
Health Care Providers & Services       33,702        33,702 
Hotels, Restaurants & Leisure       19,911        19,911 
Household Durables       23,484        23,484 
Independent Power & Renewable Electricity Producers       72,799        72,799 
Insurance       16,625        16,625 
Interactive Media & Services   2,303            2,303 
Machinery       6,790        6,790 
Media       20,582        20,582 
Metals & Mining       7,849        7,849 
Pharmaceuticals       100,964        100,964 
Real Estate Management & Development       42,990        42,990 
Software       19,107        19,107 
Transportation Infrastructure       20,802        20,802 
Total Common Stocks   2,303    536,785        539,088 
Short-Term Investment                    
Investment Company   357            357 
Total Assets  $2,660   $536,785   $   $539,445 

 

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment's valuation changes.